Variant Gene Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs1057519971
rs1057519971
0.010 GeneticVariation BEFREE We sequenced the SPOP gene to identify somatic mutations in 49 AA prostate tumors and identified three missense mutations (p.Y87C, p.F102S, and p.G111E) in five AA prostate tumors (10%) and one synonymous variant (p.I106I) in one tumor. 24994784

2015

dbSNP: rs121913430
rs121913430
A 0.700 GeneticVariation CLINVAR Prospective enterprise-level molecular genotyping of a cohort of cancer patients. 25157968

2014

dbSNP: rs2155222
rs2155222
0.010 GeneticVariation BEFREE The findings indicate the functionality of the PrCa death-predisposing SNPs rs143975731, rs12277366, rs2155225, and rs2155222 as DGAT2 regulators in prostate tumors.© 2016 Wiley Periodicals, Inc. 27113481

2016

dbSNP: rs138213197
rs138213197
0.030 GeneticVariation BEFREE Somatic molecular subtyping of prostate tumors from HOXB13 G84E carriers. 28186998

2017

dbSNP: rs1060501201
rs1060501201
0.010 GeneticVariation BEFREE Somatic molecular subtyping of prostate tumors from HOXB13 G84E carriers. 28186998

2017

dbSNP: rs1197734477
rs1197734477
0.010 GeneticVariation BEFREE Somatic molecular subtyping of prostate tumors from HOXB13 G84E carriers. 28186998

2017

dbSNP: rs1057519864
rs1057519864
AR
0.010 GeneticVariation BEFREE CDK4/6i was also effective in prostate tumor models expressing the AR-V7 variant or the AR F876L mutation, both of which are associated with treatment resistance. 28209757

2017

dbSNP: rs138213197
rs138213197
0.030 GeneticVariation BEFREE Impact of the G84E variant on HOXB13 gene and protein expression in formalin-fixed, paraffin-embedded prostate tumours. 29259341

2017

dbSNP: rs368234815
rs368234815
0.010 GeneticVariation BEFREE We show that the <i>IFNL4</i> rs368234815-ΔG allele was significantly associated with IRDS in prostate tumors and overall survival of AA patients. 30012562

2018

dbSNP: rs148609049
rs148609049
0.010 GeneticVariation BEFREE It was found to be an eQTL for ANO7 (Linear model p-values for Finnish patients p = 0.009; Camcap prostate tumor p = 2.53E-06; Stockholm prostate tumor cohort p = 1.53E-13). rs148609049 was not associated with risk, but was related to shorter survival (HR 1.56; 95% CI 1.03-2.36). 30157291

2018